Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation

References

• Chiappetta DA, Hocht C, Taira C, Sosnik A. Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micelles. Biomaterials 2011;32:2379–87
   PubMed Web of Science ®Google Scholar
• Shah CA. Adherence to high activity antiretrovial therapy (HAART) in pediatric patients infected with HIV: issues and interventions. Indian J Pediatr 2007;74:55–60
   PubMed Web of Science ®Google Scholar
• Smith KA. To cure chronic HIV infection, a new therapeutic strategy is needed. Curr Opin Immunol 2001;13:617–24
   PubMed Web of Science ®Google Scholar
• Sosnik A, Chiappetta DA, Carcaboso AM. Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead. J Control Release 2009;138:2–15
   PubMed Web of Science ®Google Scholar
• Kasim NA, Whitehouse M, Ramachandran C, et al. Molecular properties of who essential drugs and provisional biopharmaceutical classification. Mol Pharm 2004;1:85–96
   PubMed Web of Science ®Google Scholar
• Takano R, Sugano K, Higashida A, et al. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test. Pharm Res 2006;23:1144–56
   PubMed Web of Science ®Google Scholar
• Bindu Madhavi B, Kusum B, Krishna Chatanya CH, et al. Dissolution enhancement of efavirenz by solid dispersion and pegylation techniques. Int J Pharm Invest 2011;1:29–34
   Google Scholar
• Baert L, Schueller L, Tardy Y, et al. Development of an implantable infusion pump for sustained anti-HIV drug administration. Int J Pharm 2008;355:38–44
   PubMed Web of Science ®Google Scholar
• Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 2001;47:3–19
   PubMed Web of Science ®Google Scholar
• Trotta M, Gallarate M, Pattarino F, et al. Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions. J Control Release 2001;76:119–28
   PubMed Web of Science ®Google Scholar
• Liversidge GG, Conzentino P. Drug particle-size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int J Pharm 1995;125:309–13
   Web of Science ®Google Scholar
• Niwa T, Miura S, Danjo K. Design of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugs. Pharm Res 2011;28:2339–49
   PubMed Web of Science ®Google Scholar
• Park CH, Youn HR, Lee J, et al. Improved efficacy of appetite suppression by lipoic acid particles prepared by nanocomminution lipoic acid particles. Drug Dev Ind Pharm 2009;35:1305–11
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Junyaprasert VB, Souto EB, et al. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. Int J Pharm 2008;354:227–34
   PubMed Web of Science ®Google Scholar
• Muller RH, Jacobs C, Kayser O. Nanosuspensions for the formulation of poorly soluble drugs. Pharmaceutical emulsions and suspensions. New York: Marcel Dekker; 2000
   Google Scholar
• van Eerdenbrugh B, Vercruysse S, Martens JA, et al. Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions – a case study with itraconazole. Eur J Pharm Biopharm 2008;70:590–6
   PubMed Web of Science ®Google Scholar
• Singh SK, Srinivasan KK, Gowthamarajan K, et al. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide. Eur J Pharm Biopharm 2011;78:441–6
   PubMed Web of Science ®Google Scholar
• Cerdeira AM, Mazzotti M, Gander B. Miconazole nanosuspensions: influence of formulation variables on particle size reduction and physical stability. Int J Pharm 2010;396:210–18
   PubMed Web of Science ®Google Scholar
• Anagha B, Maneesh M, Ecevit B, et al. Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly watersoluble drugs. Drug Dev Ind Pharm 2011;37:963–76
   PubMed Web of Science ®Google Scholar
• Lee J, Choi JY, Park CH. Characteristics of polymers enabling nano-comminution of water-insoluble drugs. Int J Pharm 2008;355:328–36
   PubMed Web of Science ®Google Scholar
• van Eerdenbrugh B, Froyen L, Martens JA, et al. Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. Int J Pharm 2007;338:198–206
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang D, Chen M, et al. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions. Int J Pharm 2008;355:321–7
   PubMed Web of Science ®Google Scholar
• Hanafy A, Spahn-Langguth H, Vergnault G, et al. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv Drug Deliver Rev 2007;59:419–26
   PubMed Web of Science ®Google Scholar
• Shegokar R, Muller RH. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm 2010;399:129–39
   PubMed Web of Science ®Google Scholar
• Box GEP, Behnken DW. Some new three level designs for the study of quantitative variables. Technometrics 1960;2:455–75
   Google Scholar
• Ragonese R, Macka M, Hughes J, et al. The use of the Box–Behnken experimental design in the optimisation and robustness testing of a capillary electrophoresis method for the analysis of ethambutol hydrochloride in a pharmaceutical formulation. J Pharm Biomed Anal 2002;27:995–1007
   PubMed Web of Science ®Google Scholar
• Kincl M, Turk S, Vrecer F. Application of experimental design methodology in development and optimization of drug release method. Int J Pharm 2005;291:39–49
   PubMed Web of Science ®Google Scholar
• Hiremath PS, Soppimath KS, Betageri GV. Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using pampa, caco-2 and rat intestine. Int J Pharm 2009;380:96–104
   PubMed Web of Science ®Google Scholar
• Singh SP, Wahajuddin N, Tewari D, et al. Pampa permeability, plasma protein binding, blood partition, pharmacokinetics and metabolism of formononetin, a methoxylated isoflavone. Food Chem Toxicol 2011;49:1056–62
   PubMed Web of Science ®Google Scholar
• Cui J, Yu B, Zhao Y, et al. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm 2009;371:148–55
   PubMed Web of Science ®Google Scholar
• Li HL, Zhao XB, Ma YK. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 2009;133:238–44
   PubMed Web of Science ®Google Scholar
• Gao Y, Wang YQ, Ma YK, et al. Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion. Colloid Surf B 2009;71:306–14
   PubMed Web of Science ®Google Scholar
• Ghosh I, Bose S, Vippagunta R, et al. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int J Pharm 2011;409:260–8
   PubMed Web of Science ®Google Scholar
• Muller RH, Jacobs C. Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability. Int J Pharm 2002;237:151–61
   PubMed Web of Science ®Google Scholar
• Xia D, Quan P, Piao H, et al. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci 2010; 40:325–34
   PubMed Web of Science ®Google Scholar
• Ali HS, York P, Blagden N. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. Int J Pharm 2009;375:107–13
   PubMed Web of Science ®Google Scholar
• Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol 2004;56:827–40
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 2003;18:113–20
   PubMed Web of Science ®Google Scholar
• Muller RH, Keck CM. Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 2004;113:151–70
   PubMed Web of Science ®Google Scholar
• Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004;3:785–96
   PubMed Web of Science ®Google Scholar
• Pongpeerapat A, Itoh K, Tozuka Y, et al. Formation and stability of drug nanoparticles obtained from drug/pvp/sds ternary ground mixture. J Drug Deliv Sci Technol 2004;14:441–7
   Web of Science ®Google Scholar
• Palla BJ, Shah DO. Stabilization of high ionic strength slurries using surfactant mixtures: molecular factors that determine optimal stability. J Colloid Interf Sci 2002;256:143–52
   Web of Science ®Google Scholar
• Karnachi AA, Khan MA. Box–Behnken design for the optimization of formulation variables of indomethacin coprecipitates with polymer mixtures. Int J Pharm 1996;131:9–17
   Web of Science ®Google Scholar
• Berglund KD, Przybycien TM, Tilton RD. Coadsorption of sodium dodecyl sulfate with hydrophobically modified nonionic cellulose polymers. 1. Role of polymer hydrophobic modification. Langmuir 2003;19:2705–13
   Web of Science ®Google Scholar
• van Eerdenbrugh B, Vermant J, Martens JA, et al. A screening study of surface stabilization during the production of drug nanocrystals. J Pharm Sci 2009;98:2091–103
   PubMed Web of Science ®Google Scholar
• Singare DS, Marella S, Gowthamrajan K, et al. Optimization of formulation and process variable of nanosuspension: an industrial perspective. Int J Pharm 2010;402:213–20
   PubMed Web of Science ®Google Scholar
• Jackson CL, Mckenna GB. The melting behavior of organic materials confined in porous solids. J Chem Phys 1990;93:9002–11
   Web of Science ®Google Scholar
• Dodiya SS, Chavhan S, Korde A, et al. Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies. Drug Dev Ind Pharm 2012; [Epub ahead of print]. DOI: 10.3109/03639045.2012.694889
   PubMed Web of Science ®Google Scholar
• Sun W, Mao SR, Shi Y, et al. Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption. J Pharm Sci 2011;100:3365–73
   PubMed Web of Science ®Google Scholar
• Pardeike J, Strohmeier DM, Schroedl N, et al. Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines. Int J Pharm 2011;420:93–100
   PubMed Web of Science ®Google Scholar
• Dressman JB, Amidon GL, Reppas C, et al. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res 1998;15:11–22
   PubMed Web of Science ®Google Scholar
• Horter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 2001;46:75–87
   PubMed Web of Science ®Google Scholar
• Puxiu W, Qing L, Yuqiang M, et al. Improved dissolution rate and bioavailability of fenofibrate pellets prepared by wet-milled-drug layering. Drug Dev Ind Pharm 2012;38:1344–53
   PubMed Web of Science ®Google Scholar
• Kansy M, Senner F, Gubernator K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem 1998;41:1007–10
   PubMed Web of Science ®Google Scholar
• Sharma P, Varma MV, Chawla HP, et al. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies. Farmaco 2005;60:874–83
   PubMedGoogle Scholar
• Hintz RJ, Johnson KC. The effect of particle-size distribution on dissolution rate and oral absorption. Int J Pharm 1989;51:9–17
   Web of Science ®Google Scholar
• Jinno J, Kamada N, Miyake M, et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release 2006;111:56–64
   PubMed Web of Science ®Google Scholar